Health and Healthcare

Gilead Sciences : GILD

All Gilead Sciences Articles

732 Articles

Chris Lange | Jul 25, 2016 at 9:05 AM EDT

What to Expect From Gilead Sciences Earnings

Gilead Sciences is scheduled to release its second-quarter financial results after the markets close on Monday.

Chris Lange | Jul 24, 2016 at 10:12 AM EDT

10 Must-See Earnings for the Coming Week

24/7 Wall St. has put together a preview of Alphabet, Amazon.com, Facebook and some of the other major companies reporting…

Jon C. Ogg | Jul 14, 2016 at 8:40 AM EDT

5 Companies Likely Buying Back the Most Stock in June and July

With many stocks having just hit record highs, investors need at least a bit of an explanation here. One thing…

Chris Lange | Jul 13, 2016 at 8:10 AM EDT

Short Sellers Become More Selective on Major Biotechs

The June 30 short interest data have been compared with the previous report, and short interest moves were mixed in…

Chris Lange | Jul 12, 2016 at 10:10 AM EDT

Biotechs With Drug Pipelines Closest to Zero Valuation

Credit Suisse has taken a look at which biotech companies in its coverage have the least credit given to pipeline…

Jon C. Ogg | Jun 28, 2016 at 12:01 PM EDT

5 Top Biotechs Where Future Multi-Billion Dollar Drug Pipelines are Valued Almost at Zero

[cnxvideo id=”655353″ placement=”ros”]Sometimes market volatility and outside shocks create a rift between market prices and real value. That may currently…

Chris Lange | Jun 27, 2016 at 7:55 AM EDT

Short Sellers Run for Cover From Major Biotechs

The short interest data are out for the June 15 settlement date. Biotech companies are considered a riskier group of…

Jon C. Ogg | Jun 23, 2016 at 8:05 AM EDT

20 Companies Buying Back the Most Stock in 2016

Standard & Poor's has now shown that the first quarter of 2016 saw a 12% rise in buyback spending to…

Chris Lange | Jun 20, 2016 at 12:25 PM EDT

Gilead Sciences Bounces on Preliminary Results

Shares of Gilead Sciences Inc. (NASDAQ: GILD) saw make a handy gain just off of their 52-week low following the release of…

Chris Lange | Jun 10, 2016 at 8:10 AM EDT

Short Sellers Become More Selective on Major Biotechs

The May 31 short interest data have been compared with the previous report, and short interest moves were mixed in…

Jon C. Ogg | May 26, 2016 at 8:10 AM EDT

7 Companies in the Fight to Defeat the Zika Virus

Many companies are being discussed as Zika virus winners, but the reality is that many of them are so small…

Chris Lange | May 25, 2016 at 8:20 AM EDT

Short Sellers Grow More Selective on Major Biotechs

The May 13 short interest data have been compared with the previous report, and short interest moves were mixed in…

Paul Ausick | May 19, 2016 at 4:04 PM EDT

The 52-Week Low Club for Thursday

May 19, 2016: Here are four stocks trading with heavy volume among 81 equities making new 52-week lows in Thursday’s…

Chris Lange | May 11, 2016 at 8:15 AM EDT

Short Sellers Run for Cover From Major Biotechs

The short interest data are out for the April 29 settlement date, and short interest moves were mixed in these…

Chris Lange | May 3, 2016 at 1:35 PM EDT

Can Gilead Shares Still Really Rise to $150?

Gilead Sciences saw a sell-off after the company posted less than favorable earnings, but one analyst thinks that investors have…

1 … 25 26 27 28 29 … 49

Gilead Sciences : GILD

All Gilead Sciences Articles

What to Expect From Gilead Sciences Earnings

10 Must-See Earnings for the Coming Week

5 Companies Likely Buying Back the Most Stock in June and July

Short Sellers Become More Selective on Major Biotechs

Biotechs With Drug Pipelines Closest to Zero Valuation

5 Top Biotechs Where Future Multi-Billion Dollar Drug Pipelines are Valued Almost at Zero

Short Sellers Run for Cover From Major Biotechs

20 Companies Buying Back the Most Stock in 2016

Gilead Sciences Bounces on Preliminary Results

Short Sellers Become More Selective on Major Biotechs

7 Companies in the Fight to Defeat the Zika Virus

Short Sellers Grow More Selective on Major Biotechs

The 52-Week Low Club for Thursday

Short Sellers Run for Cover From Major Biotechs

Can Gilead Shares Still Really Rise to $150?

Wall Street Technician Declares Financials, Industrials, and Biotech Poised for Breakouts. 3 ETFs Could Soar.

Dividend Safety Check: Bond ETFs for Reliable Income (MUB, BND)

Dividend Safety Check: International Dividend Income with IDV

She's 81, Her House Is Paid Off, and Property Taxes Keep Rising. Can She Afford to Stay?

Could You Build Your Own "Wonderful Life" In The Town That Inspired Bedford Falls?

Wall Street Technician Declares Financials, Industrials, and Biotech Poised for Breakouts. 3 ETFs Could Soar.

Dividend Safety Check: Bond ETFs for Reliable Income (MUB, BND)

Gilead Sciences : GILD

All Gilead Sciences Articles

What to Expect From Gilead Sciences Earnings

10 Must-See Earnings for the Coming Week

5 Companies Likely Buying Back the Most Stock in June and July

Short Sellers Become More Selective on Major Biotechs

Biotechs With Drug Pipelines Closest to Zero Valuation

5 Top Biotechs Where Future Multi-Billion Dollar Drug Pipelines are Valued Almost at Zero

Short Sellers Run for Cover From Major Biotechs

20 Companies Buying Back the Most Stock in 2016

Gilead Sciences Bounces on Preliminary Results

Short Sellers Become More Selective on Major Biotechs

7 Companies in the Fight to Defeat the Zika Virus

Short Sellers Grow More Selective on Major Biotechs

The 52-Week Low Club for Thursday

Short Sellers Run for Cover From Major Biotechs

Can Gilead Shares Still Really Rise to $150?

Wall Street Technician Declares Financials, Industrials, and Biotech Poised for Breakouts. 3 ETFs Could Soar.

Dividend Safety Check: Bond ETFs for Reliable Income (MUB, BND)

Dividend Safety Check: International Dividend Income with IDV

Featured Reads

She's 81, Her House Is Paid Off, and Property Taxes Keep Rising. Can She Afford to Stay?

Could You Build Your Own "Wonderful Life" In The Town That Inspired Bedford Falls?